Search
-
Unlock your brand visibility in the AI era with Ipsos Synthesio GEO
Ipsos launches Synthesio GEO a breakthrough product offering centered around brand intelligence that enables leaders to uncover how LLMs portray their brands and categories, benchmark against competitors, and take action to shape their presence in the era of generative AI.
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.
-
Ipsos Launches AI-Powered Risk Informer for Real-Time, Project-Based Risk Monitoring
Discover How Our AI-Powered Platform Transforms Risk Management and Sustainability Compliance
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
-
ESG in life sciences as a hidden driver for brand success
There is a growing belief among the public that private corporations should also take responsibility for environmental, social, and governance (ESG) issues; these factors are no longer solely the responsibility of the public and governments. While certain business sectors are perceived as having a heightened obligation to diminish their environmental footprint (particularly energy companies, automobile manufacturers, airlines, and public transport providers), no industry can evade the necessity to act responsibly.
-
Ipsos Encyclopedia - Sample
The subset of the population or universe of interest which is interviewed.